Every stored oracle finding for this trial, including pending, dismissed, rejected, superseded, and accepted items.
NO_DECISIONDismissed100% confidenceGrok 4.20 (xAI)
Will the results be positive?
Trial NCT06290934 (GS-1427 Phase 2 UC, SWIFT) is active not recruiting, primary completion estimated Mar 2026. No public topline results, readouts, or efficacy interpretations found in searches as of Apr 2026. Sources confirm ongoing status without outcome data.
Found Apr 6, 2026, 2:59 PMReviewed Apr 6, 2026, 3:00 PM
NO_DECISIONDismissed90% confidenceGrok 4.20 (xAI)
Will the results be positive?
No public readout or efficacy results found for this Phase 2 trial (NCT06290934). Primary completion is estimated for March 2026; study is active/not recruiting or recruitment complete with no topline data posted. No sources frame results as positive or negative.
Found Apr 6, 2026, 2:10 PMReviewed Apr 6, 2026, 2:19 PM
NO_DECISIONDismissed90% confidencemanual-chat-review
Will the results be positive?
ClinicalTrials.gov still lists this study as active not recruiting with no posted results, so there is not yet a clear public positive or negative trial readout.
Found Apr 4, 2026, 8:54 PMReviewed Apr 4, 2026, 10:33 PM
NO_DECISIONDismissed92% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No trial-specific public efficacy readout was found. The cited records still describe NCT06290934/GS-1427 as an ongoing Phase 2 ulcerative colitis study rather than reporting topline or interpreted results, so the outcome cannot be classified positive or negative yet.
Found Apr 3, 2026, 4:30 PMReviewed Apr 3, 2026, 4:47 PM
NO_DECISIONDismissed93% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No trial-specific efficacy readout was found. As of the latest public records checked, NCT06290934 is still listed as ongoing/active, with no reported results on the registry and no sponsor source framing this exact Phase 2 UC trial as positive or negative.
Found Apr 1, 2026, 7:53 PMReviewed Apr 1, 2026, 7:55 PM